Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study

Fig. 2

(a) VAS score at rest and (b) its change from baseline (mITT population). Data are mean ± SD. No statistical tests were conducted for the results shown in (a); analysis by t-test was conducted to obtain the P values for intergroup differences in (b). mITT, modified intention-to-treat; SD, standard deviation; VAS, Visual Analogue Scale

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us